THE EFFICACY AND TOXICITY OF CHEMOTHERAPY WITH BEVACIZUMAB FOR PREVIOUSLY TREATED PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Itotani, R. [1 ]
Kitajima, T. [1 ]
Inoue, D. [1 ]
Takamatsu, K. [1 ]
Ishitoko, M. [1 ]
Marumo, S. [1 ]
Sakuramoto, M. [1 ]
Fukui, M. [1 ]
机构：
[1] Kitano Hosp, Resp Dis Ctr, Tazuke Kofukai Med Res Inst, Osaka, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2014年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
119P
引用
收藏
页码：S47 / S47
页数：1
相关论文
共 50 条
  • [31] Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer
    Crino, Lucio
    Bronte, Giuseppe
    Bidoli, Paolo
    Cravero, Paola
    Minenza, Elisa
    Cortesi, Enrico
    Garassino, Marina C.
    Proto, Claudia
    Cappuzzo, Federico
    Grossi, Francesco
    Tonini, Giuseppe
    Sarobba, Maria Giuseppina
    Pinotti, Graziella
    Numico, Gianmauro
    Samaritani, Riccardo
    Ciuffreda, Libero
    Frassoldati, Antonio
    Bregni, Marco
    Santo, Antonio
    Piantedosi, Francovito
    Illiano, Alfonso
    De Marinis, Filippo
    Tamberi, Stefano
    Giannarelli, Diana
    Delmonte, Angelo
    [J]. LUNG CANCER, 2019, 129 : 35 - 40
  • [32] Phase II study of the combination of S-1 with bevacizumab for patients with previously treated advanced non-squamous non-small-cell lung cancer
    Tsukasa Hasegawa
    Noriko Yanagitani
    Fumiyoshi Ohyanagi
    Keita Kudo
    Atsushi Horiike
    Yuichi Tambo
    Shingo Nishikawa
    Ryo Ariyasu
    Ken Uchibori
    Satoru Kitazono
    Makoto Nishio
    [J]. International Journal of Clinical Oncology, 2021, 26 : 507 - 514
  • [33] Phase II study of the combination of S-1 with bevacizumab for patients with previously treated advanced non-squamous non-small-cell lung cancer
    Hasegawa, Tsukasa
    Yanagitani, Noriko
    Ohyanagi, Fumiyoshi
    Kudo, Keita
    Horiike, Atsushi
    Tambo, Yuichi
    Nishikawa, Shingo
    Ariyasu, Ryo
    Uchibori, Ken
    Kitazono, Satoru
    Nishio, Makoto
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (03) : 507 - 514
  • [34] Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy
    F Grossi
    E Rijavec
    C Genova
    G Barletta
    F Biello
    C Maggioni
    G Burrafato
    C Sini
    M G Dal Bello
    K Meyer
    J Roder
    H Roder
    J Grigorieva
    [J]. British Journal of Cancer, 2017, 116 : 36 - 43
  • [35] Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy
    Grossi, F.
    Rijavec, E.
    Genova, C.
    Barletta, G.
    Biello, F.
    Maggioni, C.
    Burrafato, G.
    Sini, C.
    Dal Bello, M. G.
    Meyer, K.
    Roder, J.
    Roder, H.
    Grigorieva, J.
    [J]. BRITISH JOURNAL OF CANCER, 2017, 116 (01) : 36 - 43
  • [36] EAGLES study: First-line Bevacizumab in Combination with Chemotherapy in Elderly Patients with Advanced, Metastatic, Non-squamous Non-small Cell Lung Cancer
    De Marinis, Filippo
    Bidoli, Paolo
    Luciani, Andrea
    Amoroso, Domenico
    Tonini, Giuseppe
    Bertolini, Alessandro
    Brandes, Alba A.
    Migliorino, Maria Rita
    Favaretto, Adolfo
    Gridelli, Cesare
    [J]. ANTICANCER RESEARCH, 2017, 37 (05) : 2457 - 2464
  • [37] Phase II study of carboplatin, docetaxel and bevacizumab for chemotherapy-naïve patients with advanced non-squamous non-small cell lung cancer
    Yuichi Takiguchi
    Shunichiro Iwasawa
    Koichi Minato
    Yosuke Miura
    Akihiko Gemma
    Rintaro Noro
    Kozo Yoshimori
    Masato Shingyoji
    Mitsunori Hino
    Masahiro Ando
    Hiroaki Okamoto
    [J]. International Journal of Clinical Oncology, 2015, 20 : 659 - 667
  • [38] The efficacy and safety of pemetrexed plus bevacizumab in previously treated patients with advanced nonsquamous non-small cell lung cancer.
    Ding, Lingyu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [39] Association of the bevacizumab pharmacokinetics with efficacy and toxicity in advanced non-small cell lung cancer
    Inaba, Megumi
    Saeki, Sho
    Sasaki, Jiichiro
    Sakata, Shinya
    Sato, Ryo
    Saruwatari, Koichi
    Kishi, Hiroto
    Fujii, Shinji
    Hamada, Akinobu
    Kohrogi, Hirotsugu
    [J]. ANNALS OF ONCOLOGY, 2017, 28 : 77 - 77
  • [40] Phase II study of S-1 plus bevacizumab combination therapy for patients previously treated for non-squamous non-small cell lung cancer
    Yu Nishijima-Futami
    Seigo Minami
    Shinji Futami
    Taro Koba
    Masayoshi Higashiguchi
    Motohiro Tamiya
    Hidekazu Suzuki
    Tomonori Hirashima
    Kiyoshi Komuta
    Takashi Kijima
    [J]. Cancer Chemotherapy and Pharmacology, 2017, 79 : 1215 - 1220
12345